Gliclazide SR and Metformin SR 

Gliclazide SR and Metformin SR 
GLICLAGLAZE MET are both medications used to treat type 2 diabetes.
Gliclazide SR is a type of sulfonylurea medication that helps to lower blood sugar levels by stimulating the pancreas to release insulin. GLICLAGLAZE MET is often prescribed as a second-line therapy in patients whose blood sugar levels are not adequately controlled with lifestyle changes alone or with metformin alone.
Metformin SR is a biguanide medication that works by reducing the amount of glucose produced by the liver and improving the body's sensitivity to insulin. GLICLAGLAZE MET  is usually the first-line therapy for patients with type 2 diabetes, particularly those who are overweight or obese.
Combining GLICLAGLAZE MET can be an effective treatment option for patients whose blood sugar levels are not adequately controlled with metformin alone. The two medications work together to lower blood sugar levels through different mechanisms. However, like all medications, they may have side effects, and their use should be carefully monitored by a healthcare professional.
For further information please contact:
info@sterispharma.com